Globalization is a strong factor of change and a major challenge for organizations. With dynamic changes occurring on the market, competition becomes fierce. Therefore, companies ought to search for new ways to compete. Nowadays, organizational resources become key strategic factors for retaining market share. The best resource of Novo Nordisk is innovation reinforced by its Research and Development department. However, with the rapid growth of high technology, the company has to go an extra mile to maintain its leadership in the world’s diabetes treatment production. Using User-Driven Innovation as a unique strategy in R&D, we explain how Novo Nordisk has applied the concept in practice. Whether it is by using patients’ ideas to innovate or improve products, or as a strategy for competition. As our findings show, more value is created and co-created by involving patients in the company. Opening to a dialogue based on mutual trust, as well as formulating guidelines of practice, assists in effective cooperation. On the example of Novo Nordisk, we explain how user involvement can help understand needs and wants of patients through interaction and knowledge-sharing across the organization’s boundaries.
|Uddannelser||Virksomhedsstudier, (Bachelor/kandidatuddannelse) Kandidat|
|Udgivelsesdato||3 jun. 2019|